Electrast

Electrast is an investigational **voltage-activated ultrasound imaging agent** being developed by Sonnest for **myocardial perfusion imaging**. It is described as circulating systemically in an inactive ultrasound-dark state and then becoming selectively activated in the myocardium in response to electrical voltage, enabling contrast-enhanced assessment of cardiac perfusion at the point of care. Based on the provided information, Electrast appears to be a preclinical diagnostic imaging drug candidate intended to provide rapid, low-cost cardiac perfusion imaging without ionizing radiation or toxic contrast dyes, with the underlying technology originating at Drexel University.

Brand names

Electrast